Haemonetics Corp (HAE) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-09-26 | 2026-06-27 | 2026-03-28 | 2025-12-27 | 2025-09-27 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 5.42%357.76 | 339.38 | 346.35 | 338.97 | 327.32 |
| Cost Of Revenue | 0.20%136.85 | 136.58 | 148.14 | 136.58 | 132.57 |
| Gross Profit | 8.93%220.91 | 202.80 | 198.21 | 202.39 | 194.74 |
0.31%145.79 | 145.35 | 221.24 | 134.99 | 136.25 | |
| Selling, General, and Administrative | 0.49%118.36 | 118.94 | 120.93 | 109.15 | 101.62 |
| Research and Development | 5.12%17.03 | 16.20 | 14.45 | 14.19 | 14.87 |
| Depreciation and Amortization | 2.39%27.76 | 27.11 | 27.32 | 27.39 | 28.26 |
| Operating Income/Loss | 30.74%75.12 | 57.46 | -23.03 | 67.40 | 58.49 |
| Income/Loss From Equity Method Investments | 40.00%-1.40 | -1.00 | - | - | - |
| Income/Loss From Continuing Operations Before Tax | 32.13%62.86 | 47.57 | -28.40 | 59.98 | 51.29 |
| Income Tax Expense/Benefit, Deferred | 284.13%2.57 | 0.67 | -20.38 | -2.06 | -0.73 |
| Income Tax Expense/Benefit | 13.66%16.55 | 14.56 | -8.25 | 15.24 | 12.60 |
40.28%46.31 | 33.01 | -20.15 | 44.74 | 38.68 | |
| Attributable To Parent | 40.28%46.31 | 33.01 | -20.15 | 44.74 | 38.68 |
| Basic Average Shares | 0.31%45.50 | 45.36 | - | 46.79 | 47.59 |
| Diluted Average Shares | 1.66%46.46 | 45.70 | - | 46.99 | 47.66 |
| Basic Earnings Per Share | 39.73%1.02 | 0.73 | - | 0.96 | 0.81 |
| Diluted Earnings Per Share | 38.89%1.00 | 0.72 | - | 0.95 | 0.81 |